RECURSION PHARMACEUTICALS, INC. ($RXRX)
Filing Information
| Accession Number | 0001601830-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 6, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
160,710
Total Value
$201,695.84
P&L
+inf% (+$102,872.94)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Class A Common Stock | โ | Feb 4, 2026 | Conversion | 40,000 | $0.00 | $0.00 | 953,839 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Feb 4, 2026 | Sale | 40,000 | $4.12 | $164,800.00 | 913,839 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Feb 6, 2026 | Grant/Award | 30,346 | $0.00 | $0.00 | 944,185 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Feb 6, 2026 | Tax Withholding | 10,364 | $3.56 | $36,895.84 | 933,821 | Direct | โ | View Details | |
Director | Class B Common Stock | Derivative | Feb 4, 2026 | Conversion | 40,000 | $0.00 | $0.00 | 4,583,334 | Direct | โ | View Details |